UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Characterization of T‐DM1‐resistant breast cancer cells

Pharmacology research & perspectives, 2020-08, Vol.8 (4), p.e00617-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

PARP Inhibitors and Proteins Interacting with SLX4

Cancers, 2023-02, Vol.15 (3), p.997

Jordheim, Lars Petter

2023

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous analysis of eight nucleoside triphosphates in cell lines by liquid chromatography coupled with tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-11, Vol.877 (30), p.3831-3840

2009

Link zum Volltext

Verfügbarkeit prüfen

Expanding the clinical relevance of the 5′-nucleotidase cN-II/NT5C2

Purinergic signalling, 2018-12, Vol.14 (4), p.321-329

Jordheim, Lars Petter

2018

Link zum Volltext

Verfügbarkeit prüfen

The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer

The lancet oncology, 2011-07, Vol.12 (7), p.693-702

2011

Link zum Volltext

Verfügbarkeit prüfen

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

Frontiers in immunology, 2018-10, Vol.9, p.2100-2100

2018

Link zum Volltext

Verfügbarkeit prüfen

A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3770

2023

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic perspectives for cN-II in cancer

Current medicinal chemistry, 2013-11, Vol.20 (34), p.4292

2013

Link zum Volltext

Verfügbarkeit prüfen

Cytosolic 5′-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway

International journal of molecular sciences, 2021-07, Vol.22 (13), p.7004

2021

Link zum Volltext

Verfügbarkeit prüfen

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models

Frontiers in immunology, 2023-05, Vol.14, p.1066402-1066402

2023

Link zum Volltext

Verfügbarkeit prüfen

Cytosolic 5'-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation

International journal of molecular sciences, 2018-07, Vol.19 (7), p.2115

2018

Link zum Volltext

Verfügbarkeit prüfen

Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf

PloS one, 2015-03, Vol.10 (3), p.e0121525-e0121525

2015

Link zum Volltext

Verfügbarkeit prüfen

Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells

Pharmacology, 2018-01, Vol.102 (3-4), p.161-168

2018

Link zum Volltext

Verfügbarkeit prüfen

Toward Personalization of Cytarabine Dosing in Acute Myeloid Leukemia

Journal of clinical oncology, 2022-03, Vol.40 (7), p.784-786

Jordheim, Lars Petter

2022

Link zum Volltext

Verfügbarkeit prüfen

Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

Nature reviews. Drug discovery, 2013-06, Vol.12 (6), p.447-464

2013

Link zum Volltext

Verfügbarkeit prüfen

OXPHOS inhibitors, metabolism and targeted therapies in cancer

Biochemical pharmacology, 2023-05, Vol.211, p.115531-115531, Article 115531

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical use of biomarkers in the field of cytotoxic nucleoside analogues

Nucleosides, nucleotides & nucleic acids, 2023-10, p.1-9

Jordheim, Lars Petter

2023

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional and Metabolic Investigation in 5'-Nucleotidase Deficient Cancer Cell Lines

Cells (Basel, Switzerland), 2021-10, Vol.10 (11), p.2918

2021

Link zum Volltext

Verfügbarkeit prüfen

Cytosolic 5'-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator

Cells (Basel, Switzerland), 2021-01, Vol.10 (1), p.182

2021

Link zum Volltext

Verfügbarkeit prüfen

Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability

Clinical and experimental pharmacology & physiology, 2014-10, Vol.41 (10), p.817-824

2014

Link zum Volltext

Verfügbarkeit prüfen

The amazing cN-II, the enzyme that keeps us busy

Nucleosides, nucleotides & nucleic acids, 2022, Vol.41 (3), p.239-246

Jordheim, Lars Petter

2022

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells

Molecular cancer therapeutics, 2005-08, Vol.4 (8), p.1268-1276

2005

Link zum Volltext

Verfügbarkeit prüfen

Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie

Therapie, 2021-11, Vol.76 (6), p.597-615

2021

Link zum Volltext

Verfügbarkeit prüfen

Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie

Therapie, 2021-11, Vol.76 (6), p.597-615

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of immunotoxicitiy in biomedical research and development

Biologie aujourd'hui, 2022, Vol.216 (3-4), p.167

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(96)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(68)
Life Sciences
(50)
Humans
(48)
Cancer
(35)
Pharmacology & Pharmacy
(26)
Biochemistry & Molecular Biology
(23)
Cell Line, Tumor
(22)
Chemical Sciences
(22)
Oncology
(20)
Animals
(16)
Biochemistry, Molecular Biology
(15)
Chemistry
(15)
Physical Sciences
(14)
Proteins
(13)
Antineoplastic Agents - Pharmacology
(12)
5'-Nucleotidase - Metabolism
(11)
Gemcitabine
(10)
Nucleotidase
(10)
Chemistry, Medicinal
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of T‐DM1‐resistant breast cancer cells

PARP Inhibitors and Proteins Interacting with SLX4

Simultaneous analysis of eight nucleoside triphosphates in cell lines by liquid chromatography coupled with tandem mass spectrometry

Expanding the clinical relevance of the 5′-nucleotidase cN-II/NT5C2

The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method

Therapeutic perspectives for cN-II in cancer

Cytosolic 5′-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models

Cytosolic 5'-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation

Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf

Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells

Toward Personalization of Cytarabine Dosing in Acute Myeloid Leukemia

Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

OXPHOS inhibitors, metabolism and targeted therapies in cancer

Clinical use of biomarkers in the field of cytotoxic nucleoside analogues

Transcriptional and Metabolic Investigation in 5'-Nucleotidase Deficient Cancer Cell Lines

Cytosolic 5'-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator

Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability

The amazing cN-II, the enzyme that keeps us busy

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells

Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie

Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie

Evaluation of immunotoxicitiy in biomedical research and development

Suchergebnisse filtern